Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR

類似資料

• Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR
  著者:: Wang Fen, 等
  出版事項: (2012-08-01)
• Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer
  著者:: Wang, Yuyan, 等
  出版事項: (2017)
• Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
  著者:: Wang, Shuhang, 等
  出版事項: (2015)
• Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
  著者:: Wang, Zhijie, 等
  出版事項: (2014)
• Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
  著者:: Xinyang Du, 等
  出版事項: (2022-05-01)